Quoin Pharmaceuticals, Ltd. – NASDAQ:QNRX
Quoin Pharmaceuticals, Ltd. stock price today
$7.15
+6.60
+1200%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
Quoin Pharmaceuticals, Ltd. stock price monthly change
-16.16%
month
Quoin Pharmaceuticals, Ltd. stock price quarterly change
-16.16%
quarter
Quoin Pharmaceuticals, Ltd. stock price yearly change
-88.25%
year
Quoin Pharmaceuticals, Ltd. key metrics
Market Cap | 2.66M |
Enterprise value | N/A |
P/E | -0.12 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | 0.14 |
PEG ratio | N/A |
EPS | -7.3 |
Revenue | N/A |
EBITDA | -8.83M |
Income | -8.45M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeQuoin Pharmaceuticals, Ltd. stock price history
Quoin Pharmaceuticals, Ltd. stock forecast
Quoin Pharmaceuticals, Ltd. financial statements
| Jun 2023 | 0 | -2.10M | |
|---|---|---|---|
| Sep 2023 | 0 | -1.92M | |
| Dec 2023 | 154.77K | -2.07M | -1338.79% |
| Mar 2024 | 0 | -2.35M |
| Dec 2023 | 154.77K | -2.07M | -1338.79% |
|---|---|---|---|
| Mar 2024 | 0 | -2.35M | |
| Oct 2025 | 0 | -1.26M | |
| Dec 2025 | 0 | -1.28M |
Analysts Price target
Financials & Ratios estimates
| 2022-11-10 | -0.65546 | -0.94 |
|---|---|---|
| 2023-03-09 | -0.27113 | -0.41 |
0%
Yield TTM
| Payout ratio | 0% |
|---|
| 2019 | |
|---|---|
| 2020 | |
| 2021 | |
| 2022 | 948.34% |
| 2023 |
| Jun 2023 | 16709444 | 7.63M | 45.71% |
|---|---|---|---|
| Sep 2023 | 15067857 | 7.65M | 50.8% |
| Dec 2023 | 12169301 | 6.50M | 53.46% |
| Mar 2024 | 16123321 | 6.99M | 43.4% |
| Jun 2023 | -1.57M | 3.03M | -75K |
|---|---|---|---|
| Sep 2023 | -1.32M | 821 | -275K |
| Dec 2023 | -3.26M | 2.63M | -182.58K |
| Mar 2024 | -1.45M | -4.51M | 5.39M |
Quoin Pharmaceuticals, Ltd. alternative data
| Aug 2023 | 4 |
|---|---|
| Sep 2023 | 4 |
| Oct 2023 | 4 |
| Nov 2023 | 4 |
| Dec 2023 | 4 |
| Jan 2024 | 4 |
| Feb 2024 | 4 |
| Mar 2024 | 4 |
| Apr 2024 | 4 |
| May 2024 | 4 |
| Jun 2024 | 4 |
| Jul 2024 | 4 |
Quoin Pharmaceuticals, Ltd. other data
0.13%
+0.10%
of QNRX is owned by hedge funds
168.36K
+131.71K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jun 2024 | 0 | 297 |
| Dec 2024 | 3999999 | 0 |
| Quarter | Transcript |
|---|---|
| Q4 2023 14 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 9 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 7 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Q1 2023 12 May 2023 | Q1 2023 Earnings Call Transcript |
-
What's the price of Quoin Pharmaceuticals, Ltd. stock today?
One share of Quoin Pharmaceuticals, Ltd. stock can currently be purchased for approximately $7.15.
-
When is Quoin Pharmaceuticals, Ltd.'s next earnings date?
Unfortunately, Quoin Pharmaceuticals, Ltd.'s (QNRX) next earnings date is currently unknown.
-
Does Quoin Pharmaceuticals, Ltd. pay dividends?
No, Quoin Pharmaceuticals, Ltd. does not pay dividends.
-
How much money does Quoin Pharmaceuticals, Ltd. make?
Quoin Pharmaceuticals, Ltd. has a market capitalization of 2.66M. Quoin Pharmaceuticals, Ltd. made a loss 8.69M US dollars in net income (profit) last year or -$0.41 on an earnings per share basis.
-
What is Quoin Pharmaceuticals, Ltd.'s stock symbol?
Quoin Pharmaceuticals, Ltd. is traded on the NASDAQ under the ticker symbol "QNRX".
-
What is Quoin Pharmaceuticals, Ltd.'s primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Quoin Pharmaceuticals, Ltd.?
Shares of Quoin Pharmaceuticals, Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Quoin Pharmaceuticals, Ltd. have?
As Jul 2024, Quoin Pharmaceuticals, Ltd. employs 4 workers.
-
When Quoin Pharmaceuticals, Ltd. went public?
Quoin Pharmaceuticals, Ltd. is publicly traded company for more then 9 years since IPO on 1 Aug 2016.
-
What is Quoin Pharmaceuticals, Ltd.'s official website?
The official website for Quoin Pharmaceuticals, Ltd. is quoinpharma.com.
-
Where are Quoin Pharmaceuticals, Ltd.'s headquarters?
Quoin Pharmaceuticals, Ltd. is headquartered at 42127 Pleasant Forest Court, Ashburn, VA.
-
How can i contact Quoin Pharmaceuticals, Ltd.?
Quoin Pharmaceuticals, Ltd.'s mailing address is 42127 Pleasant Forest Court, Ashburn, VA and company can be reached via phone at +7 039804182.
Quoin Pharmaceuticals, Ltd. company profile:
Quoin Pharmaceuticals, Ltd.
quoinpharma.comExchange:
NASDAQ
Full time employees:
4
Industry:
Biotechnology
Sector:
Healthcare
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.
42127 Pleasant Forest Court
Ashburn, VA 20148-7349
Ashburn, VA 20148-7349
CIK: 0001671502
ISIN: US74907L3006
CUSIP: 74907L102
